Head-to-Head Trial in Relapsing MS - Top-Institutions - MDSpire

Head-to-Head Trial in Relapsing MS

The phase 3 OVERLORD-MS trial compared 2 anti-CD20 therapies in previously untreated adults with newly diagnosed relapsing multiple sclerosis and recent inflammatory disease activity.

By
Kathryn Wighton
July 7, 2026
6 min

Conexiant

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

#1

The New York Eye and Ear Infirmary

New York, NY
Key Differentiators
- Ophthalmology
- Neurology
#2

National Neurovision Research Institute

Unknown, Unknown
Key Differentiators
- Ophthalmology
- Neurology
#3

Haukeland University Hospital

Bergen, Norway
Key Differentiators
- Neurology
#4

University of Bergen

Bergen, Norway
Key Differentiators
- Medicine
- Neurology
#5

University of Miami

Miami, FL
Key Differentiators
- Medicine
- Neurology